-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURSymbol 22UA-
BioNTechBörse Börse FrankfurtWKNEURSymbol 22UA
-
BioNTechBörse Xetra FrankfurtEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse BerlinEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse MünchenEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse StuttgartEURSymbol 22UA
-
BIONTECH SE-ADRBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse HamburgEURSymbol 22UA
-
BIONTECH SE-ADRBörse Quotrix System der Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Gettex System der Börse MünchenEURSymbol 22UA
-
ISIN US09075V1026 WKN: A2PSR2USDSymbol BNTX
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US09075V1026
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
BioNTech SEBörse London Stock Exchange
-
WKN
Symbol 22UA
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Firmenname
BioNTech SE
Marktkapitalisierung
26.221.596.672
Mitarbeiter
3.165 (+- 43%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.800 oder 4.530 Mitarbeiter
KGV
-99999.99
EBITDA 0
PEGRatio None
Buchwert None
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 299,9 EUR +1,45%
Letzte Communitymeinungen
- 5 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
SaLyn
14.09.2021
-
Karamellsaus_55
29.08.2021
-
Zockrat
29.08.2021
Ein User hat BioNTech abonniert.
Aktionärsstruktur der BioNTech SE
Portrait der BioNTech Aktie
Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.
Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.
5 ETFs die in BioNTech investieren
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
178 News & Informationen zur BioNTech Aktie
Hong Kong eases entry rules for vaccinated residents, tourists
Vaccinated visitors from countries now categorized as 'medium-risk – which includes the US and Canada- will be able to come to the city for the first time since the pandemic started
Hong Kong Eases Entry Rules for Vaccinated Residents, Tourists
(Bloomberg) — Hong Kong will allow vaccinated tourists from all but 10 places in the world to enter the city from August 9, in a significant easing of some of…
FDA May Grant Full Approval For Pfizer Jab As Early As September
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
CDC data shows that 74% of people who tested positive for the virus in Massachusetts outbreak were fully vaccinated
A federal investigation into a COVID-19 outbreak earlier this month in a part of Massachusetts that is home to Cape Cod and Provincetown found that 74% of…
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…
mRNA-Impfstoffe: Diese Krankheiten gehören bald der Vergangenheit an
Mit den Covid-19-Impfstoffen von Biontech/Pfizer und Moderna hat die Medizinwelt Neuland betreten. Erstmals wurden mRNA-Impfungen großflächig eingesetzt. Der Erfolg soll jetzt ausgeweitet werden. Es winken Impfstoffe gegen bisher tödliche Virus-Infektionen.
GILEAD SCIENCES : ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)
U.S.
86
90
175
162
… | July 29, 2021
Pfizer says immunity drops to 83% within six months in people who got its COVID-19 shot, further bolstering the company case for a booster
The effectiveness of Pfizer’s COVID-19 shot can drop to 83% within four to six months after getting the second dose of its vaccine. This is the latest…
AstraZeneca loses money on covid-19 vaccine for second straight quarter
Results highlight the diverging fortunes of vaccine makers, after Pfizer lifted its sales forecast
Delta variant's spread challenges most stringent Covid containment zones
Read more about Delta variant's spread challenges most stringent Covid containment zones on Business Standard. An outbreak that started at an airport in the eastern Chinese city of Nanjing is testing that country's zero-tolerance measures, which are some of the most sweeping and comprehensive in the world
Big pharma quietly pushes back on global tax deal, citing covid-19 role
Drug companies mobilize in D.C., arguing competitiveness and agility are at stake
Moderna expands child vaccine trial to get more safety data
Moderna Inc. said it would expand an ongoing trial of its coronavirus vaccine in children under 12 years old to gather more safety data amid worries that messenger RNA shots may trigger rare heart side effects. “The objective is to enroll a larger safety database which increases the likelihood of…
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $286.26, marking a +1.53% move from the previous day.
Covid-19 pandemic: WTO holiday from vaccine talks draws calls for action
Read more about Covid-19 pandemic: WTO holiday from vaccine talks draws calls for action on Business Standard. Next week WTO delegates are planning to depart Geneva for their August break and, in doing so, pause their fractious debate over a proposal to waive intellectual-property protections for Covid shotS
BioNTech Provides Update On Plans To Develop Sustainable Solutions To Address Infectious Diseases On The African Continent
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022
BioNTech is
Covid-19 Vaccine Pioneer BioNTech Plans to Make New Malaria and Tuberculosis Shots in Africa
The German company said it would invest some of the profits from the vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa.
Covid-19: Why the delta variant threatens to undermine the economic recovery
Increasing vaccination rates is the most important thing we can do to sustain the economy over the next few months. Beyond that, however, full recovery might require creating new vaccines against delta and other emerging variants
How this city doubled vaccination in 2 weeks? Teslas, flats, gold in lucky draw
Of the 2.8 million people who have received at least one shot, 2.01 million have gotten two, according to a Hong Kong government statement
Covid-19 immunity wanes but third shot still rarely needed, BioNTech CEO says
Governments must decide whether to boost vulnerable people with extra dose, head of German vaccine inventor says
What makes Covid-19 delta variant such a threat? Ten questions answered
Read more about What makes Covid-19 delta variant such a threat? Ten questions answered on Business Standard. The delta variant has some characteristics that give it a better chance of causing an infection, which means it escapes initial shield provided by antibodies, but vaccinated people are at a lower risk
Moderna : U.S. CDC Says Delivered 393,929,955 Doses Of COVID-19 Vaccine As Of July 24
BioNTech SE:
* U.S. CDC SAYS DELIVERED 393,929,955 DOSES OF COVID-19
VACCINE AS
OF JULY 24 VERSUS 393,929,955 DOSES DELIVERED AS OF JULY 23
* U.S. CDC SAYS ADMINISTERED… | July 24, 2021
World Coronavirus Dispatch: Asia's travel bubbles burst even before takeoff
Read more about World Coronavirus Dispatch: Asia's travel bubbles burst even before takeoff on Business Standard. Pfizer shot halts severe illness, why vaccinated people are getting 'breakthrough' infections, and other pandemic-related news across the globe
MediciNova : BETWEEN THE IRVINE COMPANY LLC AND (Form 8-K)
BETWEEN
THE IRVINE COMPANY LLC
AND
MEDICINOVA, INC.
LEASE
… | July 23, 2021
Pfizer Covid-19 Vaccine Is Less Effective Against Delta Infections but Still Prevents Serious Illness, Israel Study Suggests
The study from Israel comes as governments around the world try to check the rampant spread of the variant.
Fighting Infectious Diseases On The African Continent
The African continent carries a disproportionately high share of the global infectious disease burden. The extraordinary scientific progress made during the
Corona-Impfstoff: Biontech SE und Pfizer mit weiterem Megadeal in den USA
Die deutsche Pharmafirma und ihr US-Partner Pfizer liefern der amerikanischen Regierung weitere 200 Millionen Dosen Impfstoff. Die modifizierte Variante soll gegen die Delta-Variante des Virus helfen.
Pfizer shot halts severe illness, allows infection in Israel
The vaccine, developed with BioNTech SE, provided 88% protection against hospitalization and 91% against severe illness for an unspecified number of people studied between June 20 and July 17, according to a report Thursday from the health ministry
BioNTech : Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S (Form 6-K)
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
… | July 23, 2021
Pfizer, BioNTech to Sell Further 200 Million Covid-19 Vaccine Doses to U.S. Government
By Robb M. Stewart
Pfizer Inc. and BioNTech SE have agreed to supply an additional 200 million doses of their Covid-19 vaccine to the U.S. government, bringing the total under their existing… | July 23, 2021
Pfizer, BioNTech Say U.S. Government To Buy Addl 200 Mln Doses Of COVID-19 Vaccine – Quick Facts
(RTTNews) – Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that the U.S. government has purchased an additional 200 million doses of th…
Longer gap between Pfizer doses boosts antibodies, study finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
U.S. Vaccine Panel Signals Preliminary Support for Covid-19 Booster Shots
A U.S. advisory panel on vaccines expressed preliminary support for giving Covid-19 boosters to the immunocompromised, and endorsed continued use of the Johnson & Johnson vaccine despite a recent health-risk warning.
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports By Reuters
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
Moderna : U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
Despite reports of a rare neurological
disorder appearing in some people who have received Johnson &
Johnson's COVID-19 vaccine, the benefits of its use
outweigh the risks, a U.S. Centers for… | July 22, 2021
Is the next Covid-19 game changer a pill?
With many in the world still unvaccinated and cases on the rise, we’ll need more than shots to keep the virus at bay. Antiviral pills may fill the gap
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
/PRNewswire/ — According to WebMD, this week the nation's top health officials said Tuesday that the Delta variant of the coronavirus is racing through North…
Why Covid-19 Vaccines Work Well Against Delta Variant
The design of the shots helps them guard against the contagious new strain, though people will probably need two doses to get full protection.
Pfizer and BioNTech to start making Covid-19 vaccine at Biovac in Cape Town
Pfizer and Nasdaq-listed BioNTech SE have signed an agreement with the Cape Town-based-Biovac Institute to make up to 100 million doses a year of Pfizer-BioNTech Covid-19 vaccine for distribution across Africa.
BioNTech SE (BNTX): Price Up $8.54 (3.48)% Over Past Day, Up $5.44 (2.2)% Over Past Hour
Flash Briefing: Riots cost SA R50bn; Pfizer to produce vaccines in Cpt; J&J vaccine less effective against delta
Pfizer to start production of its Covid-19 vaccine at a facility in Cape Town to deliver more than 100m doses annually to African nations.